Editorial introductions

Current Opinion in Neurology was launched in 1988. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of neurology is divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Martin J. McKeownMartin J. McKeownDr McKeown is the John Nichol Chair in Parkinson's Research, Professor and Head of the Division of Neurology in the Department of Medicine, and adjunct professor in the Department of Electrical and Computer Engineering at the University of British Columbia, Vancouver, Canada. He did his Engineering Physics, Medicine and Neurology training at McMaster, University of Toronto, and University of Western Ontario, Canada, respectively. He did a three-year research fellowship at the Computational Neurobiology Laboratory at the Salk Institute for Biological Studies in San Diego, USA, before being hired as an Assistant Professor of Medicine and Biomedical Engineering at Duke University, USA. He was recruited to UBC in 2003. He is currently the Medical Advisor to the Parkinson's Society of BC and Chair of the Research and Clinical Advisory Committee of Parkinson Canada. His research interests include using brain imaging to guide non-invasive neuromodulation development and privacy-compliant video monitoring technologies for Parkinson's disease. Per SvenningssonPer SvenningssonPer Svenningsson is Professor in Neurology at the Karolinska Institutet and King's College London. He received his MD and PhD from Karolinska Institutet, Sweden. He then did his postdoctoral training in the laboratory of the Nobel laureate Paul Greengard at the Rockefeller University, USA. His studies concerned GPCR neuropharmacology and signal transduction and included the discovery of p11 as an important modulator of serotonin neurotransmission. He performed his residency in Neurology at Karolinska University Hospital and became Professor in 2012 and senior consultant in 2016. Since 2018, he is also parttime Professor of Neurodegeneration at King's College London, UK. His research interests include GPCR pharmacology, Parkinson's disease both its motor and non-motor aspects and atypical parkinsonism. Studies are conducted both in preclinical models and in specimens from patients. The goal is to identify novel targets for improved diagnostics and pharmacological therapies. Biochemical, histological, pharmacological, molecular biological and behavioral techniques are used. In the clinics, he is conducting clinical trials with therapies aiming to slow down progression of Parkinson's disease or to treat debilitating symptoms of the disease. He has published more than 300 articles. He is member of the Nobel Assembly annually awarding the Nobel Prize in Physiology or Medicine, the Swedish Royal Academy of Sciences, ACNP, Academica Europae and the International Executive Committee of MDS. He delivered the Eurolife Distinguished Medal Lecture in Barcelona and the Allan D Bass lecture in Nashville. He has been awarded the Arvid Carlsson Prize.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.